Mistras Earnings Call Highlights Record Margins, Cash Strain
Mistras ((MG)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Mistras struck an upbeat tone on its earnings call, underscoring a sharp operational turnaround with record profitability and expanding margins even as cash conversion lagged. Management framed 2025 as a proof point for its strategy, highlighting strong growth in aerospace, defense, and power while acknowledging working‑capital strains and heavy investment as near‑term trade‑offs.
Broad-Based Revenue Growth and Contract Momentum
Consolidated revenue rose 5.1% in Q4 2025 versus a year earlier, powered by double‑digit gains in key verticals and several notable wins. Aerospace and defense led with a $4.5 million, or 21.9%, jump while power generation climbed $3.3 million, or 33.2%, and industrials and infrastructure grew 6.7% and 26.8%, respectively.
Record Q4 EBITDA and Margin Expansion
Profitability hit new highs as Q4 adjusted EBITDA reached $24.8 million, up 18.2% year over year. The adjusted EBITDA margin expanded 160 basis points to 13.7%, marking the highest fourth‑quarter profit margin in the company’s history and underscoring improved mix and cost discipline.
Labs and Data Solutions Show Structural Growth
The laboratories segment delivered a standout quarter, with performance surging 661% from the prior year as in‑lab demand, particularly in aerospace, accelerated. Data Solutions and PCMS software and analytics offerings also impressed, growing 20.7% in 2025 and 25.2% year over year, reinforcing the shift toward recurring, higher‑margin digital revenue.
Full-Year Gross Profit and EBITDA Reach New Records
For the full year, gross profit climbed to nearly $205 million, an increase of 6.4% versus 2024, with gross margin improving 190 basis points to 28.4%. Full‑year adjusted EBITDA set a company record at $91.1 million, with a 12.6% margin that exceeded prior guidance, signaling durable profitability gains.
Return to Positive Free Cash Flow and Solid Leverage
Management emphasized a return to positive free cash flow in 2025 and noted that the business generated cash from operations despite growth investments. Net debt ticked down to about $150 million, a $1.3 million improvement, keeping bank‑defined leverage around 2.5x, comfortably below the 3.75x covenant and giving room to pursue its deleveraging plan.
2026 Roadmap Targets Growth and Higher Margins
The company laid out a detailed 2026 roadmap, projecting revenue between $730 million and $750 million and adjusted EBITDA of $91 million to $93 million. Management plans to lift capital spending to roughly 4.5% of revenue to remove capacity bottlenecks in in‑lab aerospace and defense and reiterated ambitions for about 5% annual growth through 2030 and a 15% EBITDA margin.
Free Cash Flow Conversion Deteriorates in 2025
Despite the operational gains, full‑year free cash flow dropped sharply to $3.8 million from $27.1 million a year earlier, reflecting weaker cash conversion. The decline was tied to elevated days‑sales‑outstanding during ERP stabilization, higher restructuring outlays, and heavier growth‑oriented CapEx.
Accounts Receivable Build Adds Working-Capital Strain
Accounts receivable swelled to $154.7 million at year‑end 2025, up $27.4 million from $127.3 million a year before, adding pressure on working capital. Management attributed the increase mainly to timing issues and ERP implementation effects and flagged AR reduction as a top priority in 2026.
Restructuring and One-Off Costs Cloud Comparisons
Reorganization and related charges totaled $12.6 million in 2025, including $4.8 million in the fourth quarter alone, weighing on reported earnings and cash flow. Leadership pointed to about $7 million of incremental restructuring costs as a key factor distorting year‑over‑year comparability even as underlying operations strengthened.
Elevated CapEx Weighs on Near-Term Cash Flow
Capital expenditures rose to $29.2 million in 2025 from $23 million the prior year, a $6.2 million increase focused on lab capacity and digital initiatives. Management signaled CapEx will stay elevated at roughly 4.5% of revenue through 2027 to support Data Solutions and AI capabilities, pressuring near‑term free cash flow but framed as targeted, high‑return spending.
Oil & Gas Exposure Remains a Key Swing Factor
Oil and gas remains a major revenue contributor, and management cautioned that project timing and lab closures could lead to declines in that segment. The 2026 outlook intentionally assumes no macro rebound or acquisitions, leaving upside tied largely to how oil and gas market activity unfolds over the year.
GAAP Earnings Dip Amid Accounting Nuances
Full‑year GAAP net income fell to $16.8 million, or $0.53 per share, from $19 million, or $0.60 per share, in 2024, reflecting restructuring and other one‑time items. Management also noted reclassifications between SG&A and cost of revenue and foreign currency translation effects, making some margin lines less directly comparable.
Guidance Signals Steady Growth and Deleveraging
For 2026, Mistras guided to $730 million–$750 million in revenue and adjusted EBITDA of $91 million–$93 million, implying stable margins despite heavier CapEx at about 4.5% of sales. The company is targeting higher net income and EPS, a mid‑20% tax rate, roughly $20 million of debt reduction to bring leverage near 2.0x, and explicit efforts to improve cash conversion and reduce receivables.
Mistras’ earnings call painted a picture of a business with strengthening fundamentals and record profitability, offset by short‑term cash and working‑capital challenges. For investors, the story hinges on whether management can translate strong end‑market momentum and high‑return investments into sustained growth, better free cash flow, and a lower‑risk balance sheet over the next two years.
